4.2.3.6	(7R)-(E)-6,7-dihydrofarnesyl diphosphate	-	46050	
4.2.3.6	(7S)-(E)-6,7-dihydrofarnesyl diphosphate	modestly competitive	46051	
4.2.3.6	1-[([(Z)-[(3Z)-20-oxopregn-4-en-3-ylidene]amino]oxy)acetyl]proline	40.3% inhibition at 0.0187 mM	226157	
4.2.3.6	10-cyclopropylidene farnesyl diphosphate	mechanism-based inhibitor	52178	
4.2.3.6	10-fluorofarnesyl diphosphate	-	52179	
4.2.3.6	2-([(Z)-[(3Z)-17-hydroxy-20-oxopregn-4-en-3-ylidene]amino]oxy)-N-[2-(4-hydroxyphenyl)ethyl]acetamide	45% inhibition at 0.0187 mM	226163	
4.2.3.6	3-(1H-indol-2-yl)-N-[([(Z)-[(3Z)-20-oxopregn-4-en-3-ylidene]amino]oxy)acetyl]alanine	67.8% inhibition at 0.0187 mM	226161	
4.2.3.6	3-phenyl-4-[2-([(Z)-[(3Z)-11,17,21-trihydroxy-20-oxopregn-4-en-3-ylidene]amino]oxy)acetamido]butanoic acid	26.7% inhibition at 0.0187 mM	226172	
4.2.3.6	4-[2-([(Z)-[(3Z)-17-hydroxy-20-oxopregn-4-en-3-ylidene]amino]oxy)acetamido]-3-phenylbutanoic acid	12.2% inhibition at 0.0187 mM	226167	
4.2.3.6	benzyl triethylammonium cation	BTAC alone does not inhibit the trichodiene synthase, 5-30 microM acts as a competitive inhibitor in the presence of 5-20 microM PPi	139250